UNSPSC 51171643: Methylcellulose

This classification denotes a laxative with the molecular formula C29H54O16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0GN6F9B2Y, chemically known as (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3, 4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5, 6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane but generally known as methylcellulose, which bears US NIH Compound Identifier 44263857.

UNSPSC 51171643 Methylcellulose is a Commodity code that nominally identifies a chemical compound used as a thickening agent, binder, and film-former in pharmaceutical and food applications. However, the recent state and local solicitations tagged with this code show little direct procurement activity for methylcellulose itself. Instead, the three recorded opportunities span offender drug testing services (specimen collection, immunoassay screening, and confirmatory lab work), direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical and OTC product supply agreements—none of which center on methylcellulose as a line item. The mismatch suggests either inconsistent code assignment in state and local procurement systems or that methylcellulose appears incidentally as a minor ingredient or component within these broader pharmaceutical and testing service procurements. The issuing bodies include a county criminal-justice department (Collin County Community Supervision and Corrections), a state HHS agency (Texas Health and Human Services Commission), and a multi-state cooperative purchasing alliance (MMCAP, administered by Minnesota), reflecting fragmented buying across criminal-justice, health systems, and cooperative-purchasing vehicles.

Recent activity appears primarily in Texas and the Upper Midwest. The Collin County RFP for offender drug testing services (due July 23, 2026, estimated contract value $600,000, two-year term with three optional one-year renewals) is the most concrete opportunity but focuses on testing services rather than methylcellulose supply. The Texas HHS RFI on Direct-to-Manufacturer Prescriptions (closed April 3, 2026) sought market intelligence on prescription fulfillment models and does not reference methylcellulose. The MMCAP generic pharmaceuticals RFP (due March 26, 2026) procures multi-source drugs and OTC products through three authorized wholesalers for state and local facilities across multiple jurisdictions including Oregon and participants beyond Minnesota, but again does not isolate methylcellulose as a named deliverable. The code shows little recent activity directly attributable to methylcellulose procurement; state and local governments seeking this chemical should monitor pharmaceutical-ingredient or excipient-specific codes rather than this commodity designation.